English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 105 | Tables: 209 | Pharma & Healthcare
Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus inactivated, purified, and cracked. For the prevention of influenza caused by this type of virus.
The global market for Split Influenza Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Split Influenza Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Split Influenza Vaccine by region & country, by Type, and by Application.
The Split Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Split Influenza Vaccine.
Market Segmentation
By Company
Sanofi Pasteur
CSL Seqirus
GSK
Seqirus, Inc.
straZeneca
Dalian Yali Peak
Segment by Type:
Aldult
Child
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Split Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Split Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Split Influenza Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Split Influenza Vaccine Product Introduction
1.2 Global Split Influenza Vaccine Market Size Forecast
1.2.1 Global Split Influenza Vaccine Sales Value (2019-2030)
1.2.2 Global Split Influenza Vaccine Sales Volume (2019-2030)
1.2.3 Global Split Influenza Vaccine Sales Price (2019-2030)
1.3 Split Influenza Vaccine Market Trends & Drivers
1.3.1 Split Influenza Vaccine Industry Trends
1.3.2 Split Influenza Vaccine Market Drivers & Opportunity
1.3.3 Split Influenza Vaccine Market Challenges
1.3.4 Split Influenza Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Split Influenza Vaccine Players Revenue Ranking (2023)
2.2 Global Split Influenza Vaccine Revenue by Company (2019-2024)
2.3 Global Split Influenza Vaccine Players Sales Volume Ranking (2023)
2.4 Global Split Influenza Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Split Influenza Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Split Influenza Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Split Influenza Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Split Influenza Vaccine
2.9 Split Influenza Vaccine Market Competitive Analysis
2.9.1 Split Influenza Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Split Influenza Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Split Influenza Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Aldult
3.1.2 Child
3.2 Global Split Influenza Vaccine Sales Value by Type
3.2.1 Global Split Influenza Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Split Influenza Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Split Influenza Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Split Influenza Vaccine Sales Volume by Type
3.3.1 Global Split Influenza Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Split Influenza Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Split Influenza Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Split Influenza Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Split Influenza Vaccine Sales Value by Application
4.2.1 Global Split Influenza Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Split Influenza Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Split Influenza Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Split Influenza Vaccine Sales Volume by Application
4.3.1 Global Split Influenza Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Split Influenza Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Split Influenza Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Split Influenza Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Split Influenza Vaccine Sales Value by Region
5.1.1 Global Split Influenza Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Split Influenza Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Split Influenza Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Split Influenza Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Split Influenza Vaccine Sales Volume by Region
5.2.1 Global Split Influenza Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Split Influenza Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Split Influenza Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Split Influenza Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Split Influenza Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Split Influenza Vaccine Sales Value, 2019-2030
5.4.2 North America Split Influenza Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Split Influenza Vaccine Sales Value, 2019-2030
5.5.2 Europe Split Influenza Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Split Influenza Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Split Influenza Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Split Influenza Vaccine Sales Value, 2019-2030
5.7.2 South America Split Influenza Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Split Influenza Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Split Influenza Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Split Influenza Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Split Influenza Vaccine Sales Value
6.2.1 Key Countries/Regions Split Influenza Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Split Influenza Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Split Influenza Vaccine Sales Value, 2019-2030
6.3.2 United States Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Split Influenza Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Split Influenza Vaccine Sales Value, 2019-2030
6.4.2 Europe Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Split Influenza Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Split Influenza Vaccine Sales Value, 2019-2030
6.5.2 China Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Split Influenza Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Split Influenza Vaccine Sales Value, 2019-2030
6.6.2 Japan Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Split Influenza Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Split Influenza Vaccine Sales Value, 2019-2030
6.7.2 South Korea Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Split Influenza Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Split Influenza Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Split Influenza Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Split Influenza Vaccine Sales Value, 2019-2030
6.9.2 India Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Split Influenza Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Company Information
7.1.2 Sanofi Pasteur Introduction and Business Overview
7.1.3 Sanofi Pasteur Split Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi Pasteur Split Influenza Vaccine Product Offerings
7.1.5 Sanofi Pasteur Recent Development
7.2 CSL Seqirus
7.2.1 CSL Seqirus Company Information
7.2.2 CSL Seqirus Introduction and Business Overview
7.2.3 CSL Seqirus Split Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 CSL Seqirus Split Influenza Vaccine Product Offerings
7.2.5 CSL Seqirus Recent Development
7.3 GSK
7.3.1 GSK Company Information
7.3.2 GSK Introduction and Business Overview
7.3.3 GSK Split Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 GSK Split Influenza Vaccine Product Offerings
7.3.5 GSK Recent Development
7.4 Seqirus, Inc.
7.4.1 Seqirus, Inc. Company Information
7.4.2 Seqirus, Inc. Introduction and Business Overview
7.4.3 Seqirus, Inc. Split Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Seqirus, Inc. Split Influenza Vaccine Product Offerings
7.4.5 Seqirus, Inc. Recent Development
7.5 straZeneca
7.5.1 straZeneca Company Information
7.5.2 straZeneca Introduction and Business Overview
7.5.3 straZeneca Split Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 straZeneca Split Influenza Vaccine Product Offerings
7.5.5 straZeneca Recent Development
7.6 Dalian Yali Peak
7.6.1 Dalian Yali Peak Company Information
7.6.2 Dalian Yali Peak Introduction and Business Overview
7.6.3 Dalian Yali Peak Split Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Dalian Yali Peak Split Influenza Vaccine Product Offerings
7.6.5 Dalian Yali Peak Recent Development
8 Industry Chain Analysis
8.1 Split Influenza Vaccine Industrial Chain
8.2 Split Influenza Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Split Influenza Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Split Influenza Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Split Influenza Vaccine Market Trends
Table 2. Split Influenza Vaccine Market Drivers & Opportunity
Table 3. Split Influenza Vaccine Market Challenges
Table 4. Split Influenza Vaccine Market Restraints
Table 5. Global Split Influenza Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Split Influenza Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Split Influenza Vaccine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Split Influenza Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Split Influenza Vaccine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Split Influenza Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Split Influenza Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Split Influenza Vaccine
Table 13. Global Split Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Split Influenza Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Split Influenza Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Split Influenza Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Split Influenza Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Split Influenza Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Split Influenza Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Split Influenza Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Split Influenza Vaccine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Split Influenza Vaccine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Split Influenza Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Split Influenza Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Split Influenza Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Split Influenza Vaccine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Split Influenza Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Split Influenza Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Split Influenza Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Split Influenza Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Split Influenza Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Split Influenza Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Split Influenza Vaccine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Split Influenza Vaccine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Split Influenza Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Split Influenza Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Split Influenza Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Split Influenza Vaccine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Split Influenza Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Split Influenza Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Split Influenza Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Split Influenza Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Split Influenza Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Split Influenza Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Split Influenza Vaccine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Split Influenza Vaccine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Split Influenza Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Split Influenza Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Split Influenza Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Split Influenza Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Split Influenza Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Split Influenza Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Split Influenza Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Split Influenza Vaccine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Split Influenza Vaccine Sales Volume, (2025-2030) & (K Units)
Table 57. Sanofi Pasteur Company Information
Table 58. Sanofi Pasteur Introduction and Business Overview
Table 59. Sanofi Pasteur Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Sanofi Pasteur Split Influenza Vaccine Product Offerings
Table 61. Sanofi Pasteur Recent Development
Table 62. CSL Seqirus Company Information
Table 63. CSL Seqirus Introduction and Business Overview
Table 64. CSL Seqirus Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. CSL Seqirus Split Influenza Vaccine Product Offerings
Table 66. CSL Seqirus Recent Development
Table 67. GSK Company Information
Table 68. GSK Introduction and Business Overview
Table 69. GSK Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. GSK Split Influenza Vaccine Product Offerings
Table 71. GSK Recent Development
Table 72. Seqirus, Inc. Company Information
Table 73. Seqirus, Inc. Introduction and Business Overview
Table 74. Seqirus, Inc. Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Seqirus, Inc. Split Influenza Vaccine Product Offerings
Table 76. Seqirus, Inc. Recent Development
Table 77. straZeneca Company Information
Table 78. straZeneca Introduction and Business Overview
Table 79. straZeneca Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. straZeneca Split Influenza Vaccine Product Offerings
Table 81. straZeneca Recent Development
Table 82. Dalian Yali Peak Company Information
Table 83. Dalian Yali Peak Introduction and Business Overview
Table 84. Dalian Yali Peak Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Dalian Yali Peak Split Influenza Vaccine Product Offerings
Table 86. Dalian Yali Peak Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Split Influenza Vaccine Downstream Customers
Table 90. Split Influenza Vaccine Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Split Influenza Vaccine Product Picture
Figure 2. Global Split Influenza Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Split Influenza Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Split Influenza Vaccine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Split Influenza Vaccine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Split Influenza Vaccine Report Years Considered
Figure 7. Global Split Influenza Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Split Influenza Vaccine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Split Influenza Vaccine Revenue in 2023
Figure 10. Split Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Aldult Picture
Figure 12. Child Picture
Figure 13. Global Split Influenza Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Split Influenza Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Split Influenza Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Split Influenza Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Split Influenza Vaccine Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Global Split Influenza Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Split Influenza Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Split Influenza Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Split Influenza Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Split Influenza Vaccine Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Split Influenza Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Split Influenza Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Split Influenza Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Split Influenza Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Split Influenza Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Split Influenza Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Split Influenza Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Split Influenza Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Split Influenza Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Split Influenza Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Split Influenza Vaccine Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Split Influenza Vaccine Sales Volume (%), (2019-2030)
Figure 37. United States Split Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Split Influenza Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Split Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Split Influenza Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 43. China Split Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 45. China Split Influenza Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Split Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Split Influenza Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Split Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Split Influenza Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Split Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Split Influenza Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 55. India Split Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Split Influenza Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 57. India Split Influenza Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 58. Split Influenza Vaccine Industrial Chain
Figure 59. Split Influenza Vaccine Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
